231
Views
0
CrossRef citations to date
0
Altmetric
CASE REPORT

Bilateral Central Retinal Vein Occlusion Secondary to Leukostasis in the Setting of Diffuse Large-B Cell Lymphoma: Case Report

, , & ORCID Icon
Pages 319-322 | Received 13 Feb 2023, Accepted 23 May 2023, Published online: 27 May 2023

References

  • Jakobsen LH, Øvlisen AK, Severinsen MT, et al. Patients in complete remission after R-CHOP(-like) therapy for diffuse large B-cell lymphoma have limited excess use of health care services in Denmark. Blood Cancer J. 2022;12(1):16. doi:10.1038/s41408-022-00614-8
  • Morton LM, Wang SS, Devesa SS, Hartge P, Weisenburger DD, Linet MS. Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001. Blood. 2006;107(1):265–276. doi:10.1182/blood-2005-06-2508
  • Hui D, Proctor B, Donaldson J, et al. Prognostic implications of extranodal involvement in patients with diffuse large B-cell lymphoma treated with rituximab and cyclophosphamide, doxorubicin, vincristine, and prednisone. Leuk Lymphoma. 2010;51(9):1–10. doi:10.3109/10428194.2010.504872
  • Fend F, Ferreri AJM, Coupland SE. How we diagnose and treat vitreoretinal lymphoma. Br J Haematol. 2016;173(5):680–692. doi:10.1111/bjh.14025
  • Uhr JH, Thau A, Chung C, Zhang XC. Rare Presentation of Bilateral Central Retinal Vein Occlusion and Leukemic Retinopathy in a Young Adult Diagnosed with T-cell Acute Lymphoblastic Leukemia. Cureus. 2020;12(1):e6666. doi:10.7759/cureus.6666
  • Mashayekhi A, Shields CL, Shields JA. Iris involvement by lymphoma: a review of 13 cases. Clin Exp Ophthalmol. 2013;41(1):19–26. doi:10.1111/j.1442-9071.2012.02811.x
  • Yoshida A, Watanabe M, Ohmine K, Kawashima H. Central retinal vein occlusion caused by hyperviscosity syndrome in a young patient with Sjögren’s syndrome and MALT lymphoma. Int Ophthalmol. 2015;35(3):429–432. doi:10.1007/s10792-015-0056-8
  • Rajagopal R, Apte RS. Seeing through thick and through thin: retinal manifestations of thrombophilic and hyperviscosity syndromes. Surv Ophthalmol. 2016;61(2):236–247. doi:10.1016/j.survophthal.2015.10.006
  • Brown DM, Campochiaro PA, Singh RP, et al. Ranibizumab for macular edema following central retinal vein occlusion: six-month primary end point results of a Phase III study. Ophthalmology. 2010;117(6):1124–1133. doi:10.1016/j.ophtha.2010.02.022
  • Alexander P, Flanagan D, Rege K, Foss A, Hingorani M. Bilateral simultaneous central retinal vein occlusion secondary to hyperviscosity in Waldenstrom’s macroglobulinaemia. Eye. 2008;22(8):1089–1092. doi:10.1038/eye.2008.193